Actively Recruiting
Study of a Probiotic Supplement to Support Gut Health and Immune Development in Healthy Full-Term Newborns
Led by Hvidovre University Hospital · Updated on 2025-08-28
378
Participants Needed
2
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting the BABIES II study to evaluate the effects of a probiotic supplement on gut health, immune system development, and overall well-being in healthy full-term newborns. This randomized, double-blinded, placebo-controlled trial focuses on infants starting from 14 days old through 9 months of age, with follow-up extending to 1 year and possible long-term monitoring until 18 years old. Participants will receive either a daily probiotic dietary supplement or an identical placebo made of maltodextrin, from 14 days old until 9 months old. The study includes an 8.5-month treatment period followed by a 3-month short-term follow-up until the infants reach 1 year. The trial is conducted at a single center and uses a quadruple masking design to maintain blinding. During the study, researchers will collect stool samples and measure various outcomes including the total amount of Bifidobacteria at 3 months, stool pH, gut microbiome composition, and stool consistency at several points from birth through 1 year. Parents and infants will be monitored regularly to assess adherence and health outcomes. The overall participation may include extended observation up to 18 years to evaluate long-term effects.
CONDITIONS
Brief Title
Probiotic for Infants
Research Team
S
Sofie Ingdam Halkjær, MSc, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here